MedTrace Logo

New Treatment in Erectile Dysfunction Patients.

NCT05439486 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-06-30

No results posted yet for this study

Summary

Erectile dysfunction patients who are non responder to sildenafil will be treated with hyperbaric oxygen therapy with 100% concentration and at 2 ATM for 30 consecutive sessions each one 90 minutes and then will be reassessed.

Conditions

Interventions

DEVICE

hyperbaric oxygen therapy within hyperbaric oxygen therapy chamber.

ED patients in this group exposed to hyperbaric oxygen 100 % concentration at 2.2 ATM for 90 minutes for 30 consecutive sessions.

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Reham E Alsharkawy, Ass. prof. · Sohag university- Faculty of Medicine

  • Amr A Ali, Ass. prof. · Sohag university- Faculty of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-29
Primary Completion
2022-08-29
Completion
2022-10-29

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05439486 on ClinicalTrials.gov